Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12513-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12513-1-AP, RRID:AB_2191690
- Product name
- SMARCAL1 antibody
- Antibody type
- Polyclonal
- Description
- SMARCAL1 antibody (Cat. #12513-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Pan-cancer analysis reveals SMARCAL1 expression is associated with immune cell infiltration and poor prognosis in various cancers.
Integrated multi-omics analysis revealed that SMARCAL1 serves as an immune related prognostic marker and promotes liver cancer growth via the Hippo/YAP signaling axis.
Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer.
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
LncRNA MT1DP promotes cadmium-induced DNA replication stress by inhibiting chromatin recruitment of SMARCAL1.
Zhao WJ, Wang ML, Zhao YF, Zhao WP, Huang QH, Lu ZW, Jia F, Shi JJ, Liu BS, Han WH, Lu HW, Zhang BC, Wang ZX
Scientific reports 2025 Feb 24;15(1):6591
Scientific reports 2025 Feb 24;15(1):6591
Integrated multi-omics analysis revealed that SMARCAL1 serves as an immune related prognostic marker and promotes liver cancer growth via the Hippo/YAP signaling axis.
Huang T, Tang M, Tang Q, Di Y, Wang J, Duan Y, Zhang C, Bi F
International journal of surgery (London, England) 2025 Dec 17;112(4):10192-205
International journal of surgery (London, England) 2025 Dec 17;112(4):10192-205
Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer.
Sun BB, Wang GZ, Han SC, Yang FY, Guo H, Liu J, Liu YT, Zhou GB
Cancer letters 2024 Jun 28;592:216929
Cancer letters 2024 Jun 28;592:216929
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
Tu Q, Liu X, Yao X, Li R, Liu G, Jiang H, Li K, Chen Q, Huang X, Chang Q, Xu G, Zhu H, Shi P, Zhao B
Journal of experimental & clinical cancer research : CR 2022 Sep 15;41(1):274
Journal of experimental & clinical cancer research : CR 2022 Sep 15;41(1):274
LncRNA MT1DP promotes cadmium-induced DNA replication stress by inhibiting chromatin recruitment of SMARCAL1.
Feng W, Qi Z, Dong Z, Liu W, Xu M, Gao M, Liu S
The Science of the total environment 2022 Feb 10;807(Pt 3):151078
The Science of the total environment 2022 Feb 10;807(Pt 3):151078
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SMARCAL1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human SMARCAL1. This antibody recognizes human, mouse, rat antigen. The SMARCAL1 antibody has been validated for the following applications: ELISA, WB analysis.
